AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 6.22
-0.18 (-2.81%)
Nov 2, 2026, 4:28 PM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 857.72 million as of November 2, 2026. It is the 25,769th most valuable company in the world and the 319th biggest in Sweden. Its market cap has increased by 239.27% in one year.
Market Cap
857.72M
Enterprise Value
846.24M
Revenue
97.33M
Global Rank
Country Rank
#319 Sweden
PE Ratio
23.04
ChartMarket Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has increased from 415.42M to 857.72M, an increase of 106.47%. That is a compound annual growth rate of 9.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 857.72M | 273.20% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.54B |
| Genovis AB (publ.) | 1.46B |
| Flerie AB | 1.21B |
| Medivir AB | 967.26M |
| SynAct Pharma AB | 908.29M |
| Infant Bacterial Therapeutics AB | 885.07M |
| Oncopeptides AB | 661.32M |
| Xspray Pharma AB | 559.52M |